Voyager Therapeutics (VYGR) Competitors $2.90 -0.22 (-6.91%) As of 01:17 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock VYGR vs. NTLA, AVXL, GYRE, RCKT, BCAX, LENZ, CRON, COGT, PRTA, and ABCLShould you be buying Voyager Therapeutics stock or one of its competitors? The main competitors of Voyager Therapeutics include Intellia Therapeutics (NTLA), Anavex Life Sciences (AVXL), Gyre Therapeutics (GYRE), Rocket Pharmaceuticals (RCKT), Bicara Therapeutics (BCAX), LENZ Therapeutics (LENZ), Cronos Group (CRON), Cogent Biosciences (COGT), Prothena (PRTA), and AbCellera Biologics (ABCL). These companies are all part of the "pharmaceutical products" industry. Voyager Therapeutics vs. Intellia Therapeutics Anavex Life Sciences Gyre Therapeutics Rocket Pharmaceuticals Bicara Therapeutics LENZ Therapeutics Cronos Group Cogent Biosciences Prothena AbCellera Biologics Intellia Therapeutics (NASDAQ:NTLA) and Voyager Therapeutics (NASDAQ:VYGR) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, community ranking, analyst recommendations, institutional ownership and media sentiment. Does the media prefer NTLA or VYGR? In the previous week, Intellia Therapeutics had 22 more articles in the media than Voyager Therapeutics. MarketBeat recorded 35 mentions for Intellia Therapeutics and 13 mentions for Voyager Therapeutics. Voyager Therapeutics' average media sentiment score of 0.73 beat Intellia Therapeutics' score of 0.15 indicating that Voyager Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Intellia Therapeutics 5 Very Positive mention(s) 3 Positive mention(s) 23 Neutral mention(s) 1 Negative mention(s) 2 Very Negative mention(s) Neutral Voyager Therapeutics 5 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher earnings and valuation, NTLA or VYGR? Voyager Therapeutics has higher revenue and earnings than Intellia Therapeutics. Voyager Therapeutics is trading at a lower price-to-earnings ratio than Intellia Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIntellia Therapeutics$57.88M11.62-$481.19M-$5.25-1.24Voyager Therapeutics$80.00M2.02$132.33M-$1.13-2.59 Does the MarketBeat Community prefer NTLA or VYGR? Intellia Therapeutics received 42 more outperform votes than Voyager Therapeutics when rated by MarketBeat users. Likewise, 68.90% of users gave Intellia Therapeutics an outperform vote while only 67.97% of users gave Voyager Therapeutics an outperform vote. CompanyUnderperformOutperformIntellia TherapeuticsOutperform Votes44368.90% Underperform Votes20031.10% Voyager TherapeuticsOutperform Votes40167.97% Underperform Votes18932.03% Do institutionals and insiders believe in NTLA or VYGR? 88.8% of Intellia Therapeutics shares are held by institutional investors. Comparatively, 48.0% of Voyager Therapeutics shares are held by institutional investors. 3.2% of Intellia Therapeutics shares are held by company insiders. Comparatively, 4.5% of Voyager Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is NTLA or VYGR more profitable? Voyager Therapeutics has a net margin of 15.80% compared to Intellia Therapeutics' net margin of 0.00%. Voyager Therapeutics' return on equity of 8.33% beat Intellia Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Intellia TherapeuticsN/A -49.34% -40.27% Voyager Therapeutics 15.80%8.33%6.15% Which has more risk & volatility, NTLA or VYGR? Intellia Therapeutics has a beta of 2.23, meaning that its stock price is 123% more volatile than the S&P 500. Comparatively, Voyager Therapeutics has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Do analysts recommend NTLA or VYGR? Intellia Therapeutics currently has a consensus price target of $37.56, suggesting a potential upside of 478.22%. Voyager Therapeutics has a consensus price target of $13.97, suggesting a potential upside of 377.48%. Given Intellia Therapeutics' higher possible upside, equities analysts plainly believe Intellia Therapeutics is more favorable than Voyager Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Intellia Therapeutics 1 Sell rating(s) 6 Hold rating(s) 11 Buy rating(s) 1 Strong Buy rating(s) 2.63Voyager Therapeutics 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 1 Strong Buy rating(s) 3.11 SummaryVoyager Therapeutics beats Intellia Therapeutics on 10 of the 18 factors compared between the two stocks. Remove Ads Get Voyager Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VYGR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VYGR vs. The Competition Export to ExcelMetricVoyager TherapeuticsBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$161.48M$2.71B$5.12B$7.33BDividend YieldN/A1.52%5.35%4.28%P/E Ratio4.1229.3321.8317.50Price / Sales2.02415.29355.9888.25Price / Cash1.41168.6838.1534.64Price / Book0.543.376.103.78Net Income$132.33M-$72.06M$3.19B$247.05M7 Day Performance-5.95%-7.41%-4.26%-3.70%1 Month Performance-29.86%-21.29%-3.00%-8.61%1 Year Performance-66.87%-35.62%3.06%-6.65% Voyager Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VYGRVoyager Therapeutics4.5026 of 5 stars$2.90-6.9%$13.97+382.4%-65.8%$159.88M$80.00M4.08100Analyst ForecastGap DownNTLAIntellia Therapeutics4.3431 of 5 stars$7.11-11.9%$37.56+428.2%-72.9%$736.01M$57.88M-1.31600Gap DownHigh Trading VolumeAVXLAnavex Life Sciences3.2831 of 5 stars$8.58-1.6%$44.00+412.8%+98.6%$729.85MN/A-15.6040Analyst ForecastGap DownGYREGyre Therapeutics0.1075 of 5 stars$7.72-15.3%N/A-54.1%$722.69M$105.76M154.4040Gap DownHigh Trading VolumeRCKTRocket Pharmaceuticals4.6833 of 5 stars$6.67-12.1%$43.00+544.7%-78.7%$711.22MN/A-2.43240Analyst ForecastNews CoverageGap DownHigh Trading VolumeBCAXBicara TherapeuticsN/A$13.03-2.8%$36.50+180.1%N/A$709.04MN/A0.0032Analyst ForecastAnalyst RevisionGap DownLENZLENZ Therapeutics1.9044 of 5 stars$25.71+0.3%$41.67+62.1%-0.4%$708.13MN/A-5.39110Gap DownCRONCronos Group1.5972 of 5 stars$1.81+1.1%$3.00+65.7%-35.6%$692.38M$117.62M-13.92450Positive NewsCOGTCogent Biosciences1.9963 of 5 stars$5.99-7.6%$14.43+140.9%-36.2%$681.96MN/A-2.4280News CoverageGap DownPRTAProthena3.544 of 5 stars$12.38-5.8%$55.00+344.3%-56.4%$666.38M$135.16M-5.38130News CoverageGap DownABCLAbCellera Biologics1.9652 of 5 stars$2.23-3.5%$7.00+213.9%-54.1%$664.51M$28.83M-3.66500Gap Down Remove Ads Related Companies and Tools Related Companies Intellia Therapeutics Alternatives Anavex Life Sciences Alternatives Gyre Therapeutics Alternatives Rocket Pharmaceuticals Alternatives Bicara Therapeutics Alternatives LENZ Therapeutics Alternatives Cronos Group Alternatives Cogent Biosciences Alternatives Prothena Alternatives AbCellera Biologics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VYGR) was last updated on 4/10/2025 by MarketBeat.com Staff From Our PartnersBITCOINYou're not going to believe this. There's a bizarre new way to make money from crypto... ...and it's not...Awesomely, LLC | SponsoredWhy crypto may be the best way to play this chaotic market …Wall Street is in chaos … Over $6 trillion was wiped … in just two days. But something else was happenin...Weiss Ratings | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | SponsoredOil Surge Predicted... But Are You Ready?Do you own oil and gas stocks? Or are you thinking about buying some? But it's NOT oil stocks, futures, or ...The Oxford Club | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Voyager Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Voyager Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy VYGR Stock Free VYGR Stock Alerts